跳至主要内容
临床试验/NCT06281418
NCT06281418已完成3 期

Postoperative Pain Management Following Laparoscopic Cholecystectomy- Intraperitoneal Granisetron

Future University in Egypt1 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2024年2月29日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
46
试验地点
1
主要终点
VAS score

研究概览

简要总结

Postoperative pain management is essential and the inability to treat acute pain appropriately in the first 48 postoperative hours represents a risk factor for developing chronic pain. No. study has investigated IP granisetron as an adjuvant to standard care for postoperative pain management in patients undergoing LC.

详细描述

Postoperative pain is a main challenge for delayed hospital discharge in Laparoscopic cholecystectomy. . Postoperative pain management is essential and the inability to treat acute pain appropriately in the first 48 postoperative hours represents a risk factor for developing chronic pain. Granisetron is frequently used as a premedication to avoid postoperative nausea and vomiting in patients who have undergone general anesthesia. The purpose of this study is evaluating the efficacy and tolerability of IP granisetron on postoperative pain control in patients undergoing LC

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who are scheduled to undergo elective LC.
  • Adults (males and/or females) between the ages of 18-70 years old.

排除标准

  • Chronic pain other than cholelithiasis.
  • Patients who received analgesics or sedatives 24 h before scheduled surgery.
  • Severe hepatic (Child Pugh Class B and C) and renal dysfunction (CrCl <30ml/min)
  • Previous allergic response to granisetron.
  • Pregnancy and lactation
  • Patients with communication problems, cognitive dysfunction, or psychological disorders
  • Daily corticosteroid use

研究组 & 干预措施

Control arm

Placebo Comparator

2 ml IP normal saline (0.9 % NaCl)

干预措施: Normal saline (Other)

Intervention arm

Experimental

2ml IP granisetron (1 mg/mL)

干预措施: Granisetron 1 Mg/mL Intravenous Solution (Drug)

结局指标

主要结局

VAS score

时间窗: 2 hours, 4 hours, 8 hours, 12 hours, 24 hours

Pain intensity: VAS score

次要结局

  • Time to analgesic request(24 hours)
  • Quality of life (QoL) after laparoscopic cholecystectomy (LC)(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hoda Mohamed

Teaching Assistant- Pharmacy Practice & Clinical Pharmacy

Future University in Egypt

研究点 (1)

Loading locations...

相似试验